<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08595223925428</udiDi>
    <basicUdiDi>85952239000016X9</basicUdiDi>
    <tradeName>gb PHARM CYP2C19</tradeName>
    <deviceName>gb PHARM CYP2C19</deviceName>
    <manufacturerName>GENERI BIOTECH s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000018857</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106030104</emdnCode>
    <emdnDescription>CYP2C19</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3254-050</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-07-31T20:17:33.847Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974604720036</udiDi>
    <basicUdiDi>B-06974604720036</basicUdiDi>
    <tradeName>06974604720036</tradeName>
    <deviceName>Human CYP2C19 Gene Detection Kit(PCR-Fluorescence Method)</deviceName>
    <manufacturerName>Wuhan YZY Medical Science and Technology Co., Ltd</manufacturerName>
    <manufacturerSrn>CN-MF-000036323</manufacturerSrn>
    <authorisedRepresentativeName>RIOMAVIX SOCIEDAD LIMITADA</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000001202</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106030104</emdnCode>
    <emdnDescription>CYP2C19</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>YZYMT-006-CE</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-06T17:01:04.323Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974323012801</udiDi>
    <basicUdiDi>B-06974323012801</basicUdiDi>
    <tradeName>06974323012801</tradeName>
    <deviceName>Human CYP2C19 Gene Polymorphism Detection Kit (Fluorometric PCR)</deviceName>
    <manufacturerName>Beijing Applied Biological Technologies Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000012338</manufacturerSrn>
    <authorisedRepresentativeName>Luxus Lebenswelt GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005110</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106030104</emdnCode>
    <emdnDescription>CYP2C19</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ID013</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-06T15:51:38.731Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974323012795</udiDi>
    <basicUdiDi>B-06974323012795</basicUdiDi>
    <tradeName>06974323012795</tradeName>
    <deviceName>Human CYP2C19 Gene Polymorphism Detection Kit (Fluorometric PCR)</deviceName>
    <manufacturerName>Beijing Applied Biological Technologies Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000012338</manufacturerSrn>
    <authorisedRepresentativeName>Luxus Lebenswelt GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005110</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106030104</emdnCode>
    <emdnDescription>CYP2C19</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ID013</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-06T15:51:37.931Z</lastUpdated>
  </row>
  <row>
    <udiDi>06971532201231</udiDi>
    <basicUdiDi>B-06971532201231</basicUdiDi>
    <tradeName>06971532201231</tradeName>
    <deviceName>CYP2C19 Gene Polymorphism MCA Real-Time PCR Kit</deviceName>
    <manufacturerName>Guangzhou Hybribio Medicine Technology Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000027677</manufacturerSrn>
    <authorisedRepresentativeName>RIOMAVIX SOCIEDAD LIMITADA</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000001202</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106030104</emdnCode>
    <emdnDescription>CYP2C19</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HBRT-PGx/CPG</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-06T09:59:26.353Z</lastUpdated>
  </row>
  <row>
    <udiDi>06971532201224</udiDi>
    <basicUdiDi>B-06971532201224</basicUdiDi>
    <tradeName>06971532201224</tradeName>
    <deviceName>CYP2C19 Gene Polymorphism MCA Real-Time PCR Kit</deviceName>
    <manufacturerName>Guangzhou Hybribio Medicine Technology Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000027677</manufacturerSrn>
    <authorisedRepresentativeName>RIOMAVIX SOCIEDAD LIMITADA</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000001202</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106030104</emdnCode>
    <emdnDescription>CYP2C19</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HBRT-PGx/CPG</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-06T09:59:25.159Z</lastUpdated>
  </row>
  <row>
    <udiDi>08595223925411</udiDi>
    <basicUdiDi>85952239000016X9</basicUdiDi>
    <tradeName>gb PHARM CYP2C19</tradeName>
    <deviceName>gb PHARM CYP2C19</deviceName>
    <manufacturerName>GENERI BIOTECH s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000018857</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106030104</emdnCode>
    <emdnDescription>CYP2C19</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3254-025</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-06-30T13:57:13.650Z</lastUpdated>
  </row>
</eudamedExport>